Crizotinib/lorlatinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1941卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32418-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[1] Crizotinib/lorlatinibLack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 186 - 186
[2] LorlatinibLack of efficacy: case report
Reactions Weekly, 2024, 2023 (1) : 228 - 228
[3] LorlatinibLack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 291 - 291
[4] Crizotinib/enoxaparin-sodium/lorlatinibLack of efficacy
Reactions Weekly, 2024, 2001 (1) : 109 - 109
[5] Alectinib/lorlatinibLack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 25 - 25
[6] Alectinib/LorlatinibLack of efficacy and drug resistance : case report
Reactions Weekly, 2024, 2018 (1) : 24 - 24
[7] Crizotinib/vinblastineLack of efficacy: case report
Reactions Weekly, 2023, 1957 (1) : 183 - 183
[8] Crizotinib/LorlatinibLack of efficacy and maternal-exposure during first trimester of pregnancy
Reactions Weekly, 2024, 2014 (1) : 196 - 196
[9] LorlatinibLack of efficacy
Reactions Weekly, 2024, 2015 (1) : 230 - 230
[10] Catequentinib/crizotinib/icotinibLack of efficacy: case report
Reactions Weekly, 2022, 1932 (1) : 171 - 171

← 1 2 3 4 5 →